Basic Information
ID: ALA4041060
Type: ADME
Description: Drug level in human hepatocytes treated with [3H]-labeled N-(4-Amino-3,4-dioxo-1-phenylbutan-2-yl)-2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamide assesseed as cytosolic carbonyl reductase-mediated compound formation
Organism: Homo sapiens
Activity Charts
Bioactivity
Activity Types for Assay ALA4041060
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 459.48 | 2.26 | 2.26 |